Literature DB >> 26988505

Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein.

Hsin-Yi Lo1, Chia-Cheng Li1, Tin-Yun Ho2, Chien-Yun Hsiang3.   

Abstract

Many food bioactive peptides with diverse functions have been discovered by studying plant proteins. We have previously identified a 68-residue insulin receptor (IR)-binding protein (mcIRBP) from Momordica charantia that exhibits hypoglycemic effects in mice via interaction with IR. By in vitro digestion, we found that mcIRBP-19, spanning residues 50-68 of mcIRBP, enhanced the binding of insulin to IR, stimulated the phosphorylation of PDK1 and Akt, induced the expression of glucose transporter 4, and stimulated both the uptake of glucose in cells and the clearance of glucose in diabetic mice. Furthermore, mcIRBP-19 homologs were present in various plants and shared similar β-hairpin structures and IR kinase-activating abilities to mcIRBP-19. In conclusion, our findings suggested that mcIRBP-19 is a blood glucose-lowering bioactive peptide that exhibits IR-binding potentials. Moreover, we newly identified novel IR-binding bioactive peptides in various plants which belonged to different taxonomic families.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bioactive peptide motif; Hypoglycemic; Insulin receptor-binding protein; β hairpin

Mesh:

Substances:

Year:  2016        PMID: 26988505     DOI: 10.1016/j.foodchem.2016.02.135

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  12 in total

1.  Satietogenic Protein from Tamarind Seeds Decreases Food Intake, Leptin Plasma and CCK-1r Gene Expression in Obese Wistar Rats.

Authors:  Izael S Costa; Amanda F Medeiros; Fabiana M C Carvalho; Vanessa C O Lima; Raphael P Serquiz; Alexandre C Serquiz; Vivian N Silbiger; Raul H Bortolin; Bruna L L Maciel; Elizeu A Santos; Ana H A Morais
Journal:  Obes Facts       Date:  2018-12-11       Impact factor: 3.942

Review 2.  Revisiting amino acids and peptides as anti-glycation agents.

Authors:  H Chilukuri; M J Kulkarni; M Fernandes
Journal:  Medchemcomm       Date:  2018-02-12       Impact factor: 3.597

3.  Exploring the Factors Affecting Bitter Melon Peptide Intake Behavior: A Health Belief Model Perspective.

Authors:  Frank Pan; Pang-Kuei Hsu; Wei-Hsiu Chang
Journal:  Risk Manag Healthc Policy       Date:  2020-10-20

4.  A Treatment to Cure Diabetes Using Plant-Based Drug Discovery.

Authors:  Sumalatha Mahankali; Jagadish Kalava; Yugandhar Garapati; Bullarao Domathoti; Venkata Rao Maddumala; Venkatesa Prabhu Sundramurty
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-09       Impact factor: 2.650

5.  Hypoglycemic effects of Trichosanthes kirilowii and its protein constituent in diabetic mice: the involvement of insulin receptor pathway.

Authors:  Hsin-Yi Lo; Tsai-Chung Li; Tse-Yen Yang; Chia-Cheng Li; Jen-Huai Chiang; Chien-Yun Hsiang; Tin-Yun Ho
Journal:  BMC Complement Altern Med       Date:  2017-01-18       Impact factor: 3.659

6.  mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients' Blood Sugar Levels.

Authors:  Pang-Kuei Hsu; Frank F C Pan; Ching-Sen Hsieh
Journal:  Nutrients       Date:  2020-04-28       Impact factor: 5.717

Review 7.  Trypsin inhibitors: promising candidate satietogenic proteins as complementary treatment for obesity and metabolic disorders?

Authors:  Vanessa Cristina Oliveira de Lima; Grasiela Piuvezam; Bruna Leal Lima Maciel; Ana Heloneida de Araújo Morais
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 8.  Plant-Derived Bioactive Peptides: A Treatment to Cure Diabetes.

Authors:  Shital P Patil; Ashutosh Goswami; Kiran Kalia; Abhijeet S Kate
Journal:  Int J Pept Res Ther       Date:  2019-07-22       Impact factor: 1.931

9.  Tamarind Trypsin Inhibitor in Chitosan-Whey Protein Nanoparticles Reduces Fasting Blood Glucose Levels without Compromising Insulinemia: A Preclinical Study.

Authors:  Lídia L R Matias; Rafael O A Costa; Thaís S Passos; Jaluza L C Queiroz; Alexandre C Serquiz; Bruna L L Maciel; Pedro P A Santos; Christina S Camillo; Catarina Gonçalves; Isabel R Amado; Lorenzo Pastrana; Ana H A Morais
Journal:  Nutrients       Date:  2019-11-14       Impact factor: 5.717

10.  A randomized, double-blind, placebo-controlled trial to evaluate the hypoglycemic efficacy of the mcIRBP-19-containing Momordica charantia L. fruit extracts in the type 2 diabetic subjects.

Authors:  Yi-Sun Yang; Nian-Yi Wu; Edy Kornelius; Chien-Ning Huang; Nae-Cherng Yang
Journal:  Food Nutr Res       Date:  2022-01-03       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.